NEW YORK, June 19, 2023 /PRNewswire/ — Levi & Korsinsky notifies investors that it has commenced an investigation of Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ: RAIN) concerning possible violations of federal securities laws. On or around April 22, 2021, Rain conducted its…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.